Author

L. Fayad

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:scRNA-seq· 2 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

E. Dai· 2 shared J. Westin· 2 shared L. Nastoupil· 2 shared L. Wang· 2 shared M. R. Green· 2 shared N. Fowler· 2 shared S. Ahmed· 2 shared S. Neelapu· 2 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

E. Dai

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CD8 T-cell dysfunction is linked with CAR T-cell failure and can be mitigated by a non-alpha IL-2 agonist, pegenzileukin

P. K. Reville, I. N. Sheikh, A. Choi, E. Dai, J. Henderson, X. Li, E. Rojas, C. C. Le, C. Okwuchi, M. Devonish, R. Carrio, N. Pate, K. Malley, D. Bangari, J.-A. Givigan, , M. R. Green

The paper identifies dysfunctional CD8 CAR T-cells in rrLBCL tumors and shows that pegenzileukin mitigates this dysfunction, improving CAR T-cell responses.

bioRxiv · Aug 28, 2023 · PreprintImmunology

Immune microenvironment subtypes and association with tumor cell mutations and antigen expression in follicular lymphoma.

G. Han, Q. Deng, E. Dai, M. Dang, J. Ma, H. Yang, O. Kudryashova, M. Meerson, S. Isaev, N. Kotlov, K. Nomie, A. Bagaev, S. Parmar, F. Hagemeister, S. Ahmed, , M. R. Green

The paper identifies immune microenvironment subtypes in follicular lymphoma linked to tumor mutations and antigen expression, informing potential immunotherapeutic strategies.

bioRxiv · Apr 27, 2021 · PreprintCancer Biology